Tumour cell contamination of autologous stem cells grafts in high-risk neuroblastoma: the good news?

Br J Cancer. 2003 Jun 16;88(12):1874-7. doi: 10.1038/sj.bjc.6601014.

Abstract

We analysed the effect of graft-contaminating tumour cells on the long-term survival of 24 patients with high-risk neuroblastoma and found that patients whose grafts contained detectable neuroblastoma cells had a significantly higher probability of survival than did patients with no detectable tumour cells. Estimated contamination of the graft by more than 2000 tumour cells was associated with a significantly higher probability of survival than contamination with fewer tumour cells. We hypothesise that the presence of a critical number of graft-contaminating neuroblastoma cells can elicit a protective antitumour immune response after autologous transplantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD34*
  • Antineoplastic Agents / adverse effects
  • Bone Marrow Purging*
  • Child
  • Humans
  • Lymphopenia / chemically induced
  • Lymphopenia / therapy
  • Neuroblastoma / complications
  • Neuroblastoma / drug therapy
  • Neuroblastoma / immunology
  • Neuroblastoma / therapy*
  • Neutropenia / chemically induced
  • Neutropenia / therapy
  • Retrospective Studies
  • Risk
  • Stem Cell Transplantation*
  • Survivors
  • Transplantation, Autologous

Substances

  • Antigens, CD34
  • Antineoplastic Agents